<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03262675</url>
  </required_header>
  <id_info>
    <org_study_id>DAC-002-NATUREHF</org_study_id>
    <nct_id>NCT03262675</nct_id>
  </id_info>
  <brief_title>NAtional TUnisian REgistry of Heart Failure</brief_title>
  <acronym>NATURE-HF</acronym>
  <official_title>National Tunisian Registry of Heart Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dacima Consulting</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Société Tunisienne de Cardiologie &amp; de Chirurgie Cardio-Vasculaire</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Dacima Consulting</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      NATURE-HF is an observational, multicentric and longitudinal study of heart failure performed
      with 100 tunisian cardiologists.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The NATURE-HF is a national clinical non-interventional registry of heart failure, carried
      out in Tunisia at cardiology departments in hospitals and in liberal cardiology
      consultations. 100 cardiologists participate in the enrollment of the eligible patients as
      investigators. A Committee of Experts validates the protocol methodology and supervises the
      data-management. A Steering Committee helps investigators to monitor their patient
      inclusions, performs audit trails and prepares the statistical analysis plan for the study.

      Collected data are managed by the DACIMA Clinical Suite®, the electronic data capture
      platform which complies with the FDA 21 CFR part 11 requirements (Food and Drug
      Administration 21 Code of Federal Regulations part 11), the HIPAA specifications (Health
      Insurance Portability and Accountability Act), and the ICH standards (International
      Conference on Harmonisation).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 16, 2017</start_date>
  <completion_date type="Actual">January 12, 2019</completion_date>
  <primary_completion_date type="Actual">November 22, 2017</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>12 Months</target_duration>
  <primary_outcome>
    <measure>Cardiovascular death</measure>
    <time_frame>Time-To-Event measure up to 12 months from baseline</time_frame>
    <description>Incidence of cardiovascular death including sudden death, death from refractory heart failure and death from stroke</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Heart Failure Readmission</measure>
    <time_frame>At 1, 3 and 12 months from patient enrollment</time_frame>
    <description>Incidence of heart failure readmissions</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Global Death</measure>
    <time_frame>Time-To-Event measure up to 12 months from baseline</time_frame>
    <description>Incidence of death of all causes (cardiovascular death and non-cardiovascular death)</description>
  </secondary_outcome>
  <enrollment type="Actual">2040</enrollment>
  <condition>Heart Failure</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with heart failure
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient with chronic heart failure

          -  Patient with acute heart failure (new onset or not)

          -  The diagnosis of heart failure is at the discretion of the investigator

          -  Informed and signed consent

        Exclusion Criteria:

          -  Life expectancy &lt;12 months for extra cardiac disease

          -  Isolated Right Heart Failure

          -  Pregnant woman

          -  Renal failure with creatinine clearance &lt; 15 ml / min

          -  Hemodialysis patients

          -  Cardiac surgery planned within 3 months

          -  Congenital heart disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Faouzi Addad, Professor</last_name>
    <role>Study Chair</role>
    <affiliation>Société Tunisienne de Cardiologie et de Chirurgie Cardiovasculaire</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Société Tunisienne de Cardiologie &amp; de Chirurgie Cardio-Vasculaire</name>
      <address>
        <city>Tunis</city>
        <state>Tunisie</state>
        <zip>1000</zip>
        <country>Tunisia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Tunisia</country>
  </location_countries>
  <link>
    <url>https://www.sciencedirect.com/science/article/pii/S1878648019305956</url>
    <description>Management of Heart Failure (HF): Is there a difference in genders? Results from the NATURE-HF Registry</description>
  </link>
  <link>
    <url>https://www.sciencedirect.com/science/article/pii/S1878648019306135</url>
    <description>Epidemiological profile and pronostic impact of patients with heart failure and atrial fibrillation: Results from the NATURE HF registry</description>
  </link>
  <link>
    <url>https://www.sciencedirect.com/science/article/pii/S1878648019306214</url>
    <description>Influence of chronic kidney disease on patients with heart failure outcome</description>
  </link>
  <link>
    <url>https://www.sciencedirect.com/science/article/pii/S187864801930607X</url>
    <description>Influence of age on the treatment of heart failure (HF) with reduced ejection fraction: From a Tunisian registry NATURE HF</description>
  </link>
  <link>
    <url>https://www.sciencedirect.com/science/article/pii/S1878648019306123</url>
    <description>Impact of diabetes on heart failure outcomes: Results from NATURE-HF</description>
  </link>
  <link>
    <url>https://www.sciencedirect.com/science/article/pii/S187864801930610X</url>
    <description>Epidemiology, management, and outcomes of heart failure in Tunisia: Results from the Nature-HF registry</description>
  </link>
  <link>
    <url>https://www.sciencedirect.com/science/article/pii/S1878648019307815</url>
    <description>National Tunisian Registry of Atrial Fibrillation (NATURE-AF): Baseline results</description>
  </link>
  <link>
    <url>https://www.sciencedirect.com/science/article/pii/S1878648019306226</url>
    <description>Real-life data on heart failure and implantation of resynchronization devices in Tunisia</description>
  </link>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>August 22, 2017</study_first_submitted>
  <study_first_submitted_qc>August 24, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">August 25, 2017</study_first_posted>
  <last_update_submitted>January 17, 2020</last_update_submitted>
  <last_update_submitted_qc>January 17, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Heart Failure</keyword>
  <keyword>Acute Heart Failure</keyword>
  <keyword>Chronic Heat Failure</keyword>
  <keyword>Cardiovascular diseases</keyword>
  <keyword>Heart diseases</keyword>
  <keyword>Registry</keyword>
  <keyword>Tunisia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Clinical Study Report</ipd_description>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_time_frame>Already available</ipd_time_frame>
    <ipd_access_criteria>Free access</ipd_access_criteria>
    <ipd_url>http://www.stcccv-tunisie.com/files/RegistreNatureHF_SFC2019.pdf</ipd_url>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

